{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:41:14Z","timestamp":1787024474534,"version":"build-2736575974"},"reference-count":42,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BTT"],"DOI":"10.2147\/btt.s532526","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T15:25:14Z","timestamp":1752506714000},"page":"415-422","source":"Crossref","is-referenced-by-count":3,"title":["Brodalumab for Moderate-to-Severe Psoriasis: A Comprehensive Review of Efficacy, Safety, and Clinical Positioning"],"prefix":"10.2147","volume":"Volume 19","author":[{"given":"Nickoulet","family":"Babaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3314-1841","authenticated-orcid":true,"given":"Minka","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireya","family":"Cervantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahyeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seanna","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jashin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1080\/09546634.2017.1395800","volume":"29","author":"Wu","year":"2017","journal-title":"J Dermatol Treat"},{"key":"ref2","first-page":"S19","volume":"15","author":"Martin","year":"2022","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e29536","DOI":"10.7759\/cureus.29536","volume":"14","author":"Dhabale","year":"2022","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/ijms20061475","volume":"20","author":"Rendon","year":"2019","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jaut.2015.07.008","volume":"64","author":"Harden","year":"2015","journal-title":"J Autoimmun"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.2147\/DDDT.S113683","volume":"11","author":"Roman","year":"2017","journal-title":"Drug Des Devel Ther"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1358\/dot.2017.53.5.2613690","volume":"53","author":"Puig","year":"2017","journal-title":"Drugs Today"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12016-012-8307-1","volume":"44","author":"Raychaudhuri","year":"2012","journal-title":"Clin Rev in Allergy Immunol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1056\/NEJMra0707449","volume":"361","author":"Miossec","year":"2009","journal-title":"New Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrd3794","volume":"11","author":"Miossec","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/2040622318759282","volume":"9","author":"Chan","year":"2018","journal-title":"Ther Adv Chronic Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/jid.2012.194","volume":"133","author":"Martin","year":"2012","journal-title":"J Invest Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.4049\/jimmunol.1201505","volume":"190","author":"Johnston","year":"2013","journal-title":"J Immunol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1365-2133.2008.08902.x","volume":"160","author":"Johansen","year":"2009","journal-title":"Br J Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1016\/j.jid.2016.06.009","volume":"136","author":"Senra","year":"2016","journal-title":"J Invest Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2147\/ITT.S240891","volume":"10","author":"Mosca","year":"2021","journal-title":"ImmunoTargets Ther"},{"key":"ref17","unstructured":"Fala L. Siliq (Brodalumab): a new IL-17RA antagonist approved for moderate-to-severe plaque psoriasis. Am Health Drug Benefits. Available from: https:\/\/www.ahdbonline.com\/issues\/2018\/april-2018-vol-11-ninth-annual-payers-guide\/siliq-brodalumab-a-new-il-17ra-antagonist-approved-for-moderate-to-severe-plaque-psoriasis. Accessed January 30, 2025."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1038\/jid.2012.163","volume":"132","author":"Papp","year":"2012","journal-title":"J Invest Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1056\/NEJMoa1109017","volume":"366","author":"Papp","year":"2012","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.jaad.2014.08.039","volume":"71","author":"Papp","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s40257-019-00466-2","volume":"20","author":"Lebwohl","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/bjd.14493","volume":"175","author":"Papp","year":"2016","journal-title":"Br J Dermatol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1056\/NEJMoa1503824","volume":"373","author":"Lebwohl","year":"2015","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/jdv.16932","volume":"35","author":"Pinter","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00403-019-01907-y","volume":"311","author":"Gasslitter","year":"2019","journal-title":"Arch Dermatol Res"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.jaad.2019.05.007","volume":"81","author":"Kimmel","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1080\/09546634.2020.1716932","volume":"32","author":"Kromer","year":"2020","journal-title":"J Dermatol Treat"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"AB214","DOI":"10.1016\/j.jaad.2020.06.946","volume":"83","author":"Politou","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15106","volume":"34","author":"Loft","year":"2021","journal-title":"Dermatol Ther"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.jaad.2020.11.013","volume":"84","author":"Yeung","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/bjd.16464","volume":"179","author":"Papp","year":"2018","journal-title":"Br J Dermatol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s13555-020-00411-w","volume":"10","author":"Menter","year":"2020","journal-title":"Dermatol Ther"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1111\/jdv.17433","volume":"35","author":"Reich","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"adv00683","DOI":"10.2340\/actadv.v102.1993","volume":"102","author":"Reich","year":"2022","journal-title":"Acta Derm Venereol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jaad.2017.08.024","volume":"78","author":"Lebwohl","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s13555-024-01304-y","volume":"15","author":"Lebwohl","year":"2025","journal-title":"Dermatol Ther"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1196966","DOI":"10.3389\/fmed.2023.1196966","volume":"10","author":"Gargiulo","year":"2023","journal-title":"Front Med"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/jdv.19816","volume":"38","author":"Rigopoulos","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.2147\/CCID.S423234","volume":"16","author":"Cacciapuoti","year":"2023","journal-title":"Clin Cosmet Invest Dermatol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2023.2199108","volume":"34","author":"Ibba","year":"2023","journal-title":"J Dermatol Treat"},{"key":"ref41","unstructured":"Siliq REMS Program [homepage on the Internet]. Bridgewater, NJ: Bausch Health; 2024. Available from: https:\/\/www.siliq.com\/hcp\/siliq-rems\/about-siliq-rems\/. Accessed February 25, 2025."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1124628","DOI":"10.3389\/fphar.2023.1124628","volume":"14","author":"Deng","year":"2023","journal-title":"Front Pharmacol"}],"container-title":["Biologics: Targets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/104830","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/104830","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T15:25:16Z","timestamp":1752506716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/brodalumab-for-moderate-to-severe-psoriasis-a-comprehensive-review-of--peer-reviewed-fulltext-article-BTT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":42,"URL":"https:\/\/doi.org\/10.2147\/btt.s532526","relation":{},"ISSN":["1177-5491"],"issn-type":[{"value":"1177-5491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}